Search
Menu
Press releases
Here you can find press releases on recent topics related to new product launches, technologies, services, partnerships and organisational changes in chronological order. All press releases are also available for download as PDF.
2022
2022/05/25 | Norderstedt, Germany
Sysmex Europe SE and Sysmex Inostics GmbH launch two CE-IVD certified Plasma-SeqSensei™ liquid biopsy kits: Solid Cancer IVD Kit and Breast Cancer IVD Kit
Sysmex Inostics, a global leader in blood-based circulating tumour DNA (ctDNA) analysis, together with Sysmex Europe SE, announce the introduction of two IVD-certified Plasma-SeqSensei™ (PSS) kits to the EMEA region.
more
2022/04/22 | Norderstedt, Germany
Sysmex Europe ranks among Germany’s Top 100 employers by Great Place To Work®
Sysmex Europe is proud to announce that Sysmex Europe SE is listed in the top 100 best workplaces by Great Place To Work® Deutschland again this year. It is ranked 17th in the ‘501-2000 employees’ category.
more
2022/04/11 | Norderstedt, Germany
Sysmex Europe has launched its new three-part differential automated haematology analyser XQ-320, adding excellence in quality to this important market segment
more
2022/04/11 | Norderstedt, Germany
Sysmex Europe launches CE-IVD-marked Flow Cytometer XF-1600, offering clinical flow cytometry laboratories robust and reliable immunophenotyping
more
2022/03/01 | Norderstedt, Germany
Sysmex Europe will exhibit at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine in Munich, Germany, 11–13 April 2022
Sysmex Europe will be present at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which will take place in Munich, Germany, from 10 to 14 April 2022.
more
2022/02/15 | Kobe, Japan
Sysmex Establishes Subsidiary in Saudi Arabia
Reinforcing Sales, Service, and Support Structures to Expand Business in a Growing Market
more
2022/01/05 | Kobe, Japan
Sysmex Files for Manufacturing and Marketing Approval for an Assay Kit that Assists in Identification of Amyloid Beta (Aβ) Accumulation in the Brain
Measurement of Plasma Aβ Using Automated Immunoassay System HISCL-5000/HISCL-800
more
2021
2021/10/20 | Norderstedt, Germany
Sysmex Europe and Inpeco launch the next gamechanger in urinalysis
Read more about the first and only bi-directional system that transports racks between the Sysmex UN-Series urinalysis analysers and Inpeco's TLA system.
more
2021/10/04 | Kobe, Japan
Sysmex Launches CaresphereTM XQC, an External Quality Assessment App
Enhancing the Reliability of Testing Results and Efficiency of Laboratory Operations with the Expansion of Caresphere
more
2021/09/30 | Norderstedt, Germany
Sysmex Europe plans new working environments in the new headquarters in Hamburg
The Sysmex Group, international manufacturer and provider of innovative analytical instruments and services for laboratory diagnostics, is on a continuous course of growth and innovation. To accommodate this development, Sysmex Europe will relocate its headquarters for the EMEA region (Europe, Middle East and Africa) from Norderstedt to Hamburg.
more
2021/09/14 | Norderstedt, Germany
Sysmex launches its Sample Preparation System PS-10 in EMEA – a new product to make clinical flow cytometry testing more efficient
Sysmex Europe GmbH announces the launch of the automated flow cytometry sample preparation system PS-10 in the EMEA region.
more
2021/07/13 | Norderstedt, Germany
Sysmex launches new products for the haemostasis field in the EMEA region: automated blood coagulation analysers CN-3500 and CN-6500 using chemiluminescence enzyme immunoassay (CLEIA) technology to enhance the testing workflow
Sysmex Europe GmbH launches new haemostasis analysers CN-3500 and CN-6500 that can run chemiluminescence enzyme immunoassays to enhance the testing workflow.
more
2021/06/18 | Norderstedt, Germany
Sysmex launches HISCL™-5000 and the HISCL™ SARS-CoV-2 Ag Assay Kit in EMEA.
Sysmex Europe GmbH announces the launch of the HISCL™-5000 fully automated random-access immunochemistry analyser and the HISCL™ SARS-CoV-2 Ag Assay Kit in the EMEA region.
more
2021/06/16 | Norderstedt, Germany
Sysmex obtains the first IVDR certification for LYNOAMP™ CK19 E, a Gene Amplification Detection Reagent
more
2021/04/01 | Norderstedt, Germany
Sysmex launches Plasma-SeqSensei™ liquid biopsy RUO kits in EMEA
Sysmex Europe GmbH, together with Sysmex Inostics GmbH, announced today that they will launch the Plasma-SeqSensei™ liquid biopsy research use only (RUO) kits for colorectal cancer (CRC), non-small cell lung cancer (NSCLC), melanoma and thyroid cancer.
more
2021/03/31 | Norderstedt, Germany
Sysmex Europe and Sysmex Germany rank among Germany’s Top 100 employers by Great Place to Work®
Sysmex Europe GmbH, together with Sysmex Deutschland GmbH, is officially ranked among Germany’s top 100 employers by Great Place to Work®.
more
2021/03/08 | Kobe, Japan
Sysmex Presents Academic Report on Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
Presenting the Most Recent Data at the 15th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2021)
more
2021/02/03 | Kobe, Japan
Sysmex Corporation Announces Business Results for the First Nine Months of the Fiscal Year Ending March 31, 2021
more
2021/02/03 | Kobe, Japan
Sysmex and Siemens Healthineers Extend Long-standing Global Alliance in Hemostasis Testing
more
2021/02/03 | Kobe, Japan
Sysmex establishes new subsidiary in Portugal
Increasing Portuguese Market Presence by Enhancing Sales and After-Sales Support Networks
more
2021/01/26 | Kobe, Japan
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Fourth Time
more
2021/01/25 | Kobe, Japan
Sysmex and Roche Renew Agreement for Global Alliance
Transforming a long-standing alliance into one for the next generation
more
2020
2020/12/23 | Kobe, Japan
Sysmex Obtains Marketing Approval for the HISCLTM IFN-λ3 Assay Kit, a Test Kit to Assist in Determining Exacerbation Risk in Novel Coronavirus (SARS-CoV-2)-Positive Patients
Target market: Japan
more
2020/12/03 | Kobe, Japan
Sysmex Launches Surgical Robot Unit, hinotoriTM Surgical Robot System
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today that it will launch the hinotori Surgical Robot System, a surgical robot unit, and the HF Series Instrument, a reusable active endotherapy device (collectively referred to as "hinotori" hereinafter; manufacturer: Medicaroid Corporation [HQ: Kobe, Japan; President: Kaoru Asano]) on December 4, 2020 for medical institutions in Japan.
more
2020/11/09 | Kobe, Japan
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood - CTAD
The Content Presented at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
more
2020/09/29 | Kobe, Japan
Sysmex Applies for Manufacturing and Marketing Approval for a SARS-CoV-2 Antigen Detection Reagent
Detecting SARS-CoV-2 Antigens Using Fully Automated Immunoassay Systems HISCLTM-5000 / HISCLTM-800
more
2020/08/11 | Kobe, Japan
Medicaroid receives Japanese regulatory approval for the “hinotori TM Surgical Robot System”, the first made-in-Japan robotic assisted surgery system
more
2020/08/11 | Kobe, Japan
Collaboration of Medicaroid, Kawasaki Heavy Industries and Sysmex for the business of the“hinotori TM Surgical Robot System”, a robotic assisted surgery system
more
2020/07/27 | Kobe, Japan
Sysmex Launches OncoGuideTM NET Expert Panel Support System in Cancer Genome Profiling
- Supporting the Establishment of a System for Efficient Cancer Genomic Medicine -
more
2020/07/27 | Kobe, Japan
Sysmex Launches Lab Assay Service for Research on Cytokines Related to the Novel Coronavirus (SARS-CoV-2)
- Aiming to Monitor the Risk of Increasing Severity and Treatment Effects in Clinical Applications-
more
2020/06/01
Sysmex and OPTiM Jointly Establish New Company to Plan, Develop and Operate Medical AI and IoT Open Platforms and Digital Transformation Solutions
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and OPTiM Corporation (HQ: Minato-ku, Tokyo, Japan; President: Shunji Sugaya) jointly established and began conducting operations at D’PULA Medical Solutions Corporation on June 1, 2020. The company is in charge of planning, developing, and operating solution services that leverage open platforms and applications related to digital medicine.
more
2020/05/25 | Kobe, Japan
Sysmex Donates ¥30 Million to Kobe City Support Fund for Medical Professionals to Support COVID-19 Countermeasures
Our thoughts and prayers are with the families of those who have perished as a result of the novel coronavirus (COVID-19), and we offer our heartfelt sympathy to the patients currently suffering from this disease. We are truly grateful for the efforts of the medical community and all others who are working on the front lines to stop this pandemic from spreading. Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has decided to donate ¥30 million to the Kobe City Support Fund for Medical Professionals to support measures for countering COVID-19.
more
2020/03/05
Sysmex Presents Academic Report Related to the Clinical Utility of RAS Gene Mutation Testing for Colorectal Cancer Using Liquid Biopsy
Details of Report on Clinical Utility of OncoBEAM TM RAS CRC Kit presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2020 (ASCO-GI 2020)
more
2020/01/29
Sysmex Invests in Astrego Diagnostics with a View to Developing New Urinalysis Solutions for the Primary Care Business
more
2020/01/14
Hitado GmbH becomes Nexus IB10 distributor for sphingotec in Germany and Switzerland
more
2019
2019/12/02
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
Presenting the Most Recent Data at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
more
2019/11/07
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31
more
2019/11/05
Sysmex Wins Awards in 2019 Kinki Local Commendations for Innovations
more
2019/11/01
Sysmex and OPTiM Reach a Basic Agreement on the Establishment of a Joint Venture to Accelerate the Commercialization of Digital Medicine to Support Next-Generation Healthcare and Diagnostics
Aiming toward the Early-Stage Provision of Platforms and Applications Related to Digital Medicine
more
2019/10/30
Industry, Government and Academia Jointly Establish a General Incorporated Association to Promote the Bioresource Business
Jointly Established by Kobe University, the City of Kobe, the Foundation for Biomedical Research and Innovation at Kobe, and Sysmex
more
2019/10/02
Knowledge Is Power - Celebrating 10 Years of Sysmex Academy and More
more
2019/09/19
Sysmex Launches Caresphere™ QM, an Operational Support System for Testing Quality Management
Realizing the Operation of High-Quality Clinical Laboratories through our New Caresphere™ Solution
more
2019/09/17
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year
more
2019/09/03
Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”
-Using Unique Technology to Cultivate True Automation in Blood Cell Counting-
more
2019/07/19
Liquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal)
more
2019/06/04
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
Contributing to Clean and Fair Sports Management by Enhancing the Quality of Doping Tests
more
2019/05/30
Sysmex Inostics OncoBEAM™-EGFR digital PCR liquid biopsy demonstrates two-fold higher detection of p.T790M mutations in 183 NSCLC patients in comparison study
more
2019/05/28
Sysmex Inostics’ SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM™ enhanced digital PCR technology for detection of mutations in circulating tumor DNA
more
2019/05/08
Promoting Business Process Restructuring through Digitalization to Reinforce Corporate Foundations and Create New Value
more
2019/05/08
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
Strengthening Diagnostic Reagent Functions through an Integrated Structure from the Development of Substances to the Development, Production and Distribution of Bio-Diagnostic Reagents
more
2019/04/25
Sysmex Obtains CE Certification for Automated Hematology Analyzer XN-31, Which Has an Automatic Measurement Function for Red Blood Cells Infected by Malaria Parasites
Contributing to the Early Detection and Treatment of Malaria through Standardized and More Efficient Malaria Testing
more
2019/03/01
Sysmex to Be Special Sponsor of the Kobe Marathon 2019
-We are pleased to have sponsored this exciting event since its inception in 2011-
more
2018
2018/12/04
With a View to New Value Creation, Sysmex Launches a Research Assay Service for HDL Function Measurement
-Aiming to Prevent Atherosclerosis-Related Diseases and Provide Treatment Opportunities-
more
2018/12/03
Sysmex Launches Revohem FIX Chromogenic, a Blood Coagulation Factor IX Measurement Kit
-Japan’s First Coagulation Factor IX Measurement Kit Using Chromogenic Assay, Helping to Diagnose and Assist in the Treatment of Hemophilia B-
more
2018/11/28
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
-To Accelerate Precision Medicine Through Globally Proven Experience-
more
2018/11/26
CALiaGold – The new quantitative immunoassay from Sentinel Diagnostics for calprotectin measurement in SENTiFIT 270 Analyser
more
2018/11/05
Sysmex Inostics OncoBEAM™ circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers
more
2018/10/22
Strengthening Our Global R&D Structure to Foster Early-Stage Innovation
more
2018/10/18
Sysmex Inostics´ OncoBEAM™ platform demonstrates superior detection of clinically-relevant mutations for therapy selection and molecular monitoring for lung and colon cancers
more
2018/10/02
In vitro diagnostics company Sysmex Europe announces executive leadership change
more
2018/09/28
Sysmex Inostics announces launch of OncoBEAM™ EGFR Kit v2 (RUO) in Europe and Asia
more
2018/08/31
Sysmex, Toppan Printing, and RIKEN GENESIS Commence Launch of Fully Automated System (Research Use Only) to Detect Gene Mutations in Cancer Tissue
-Streamlining the Gene Testing Processes to Standardize the Testing-
more
2018/08/08
Sysmex Partec’s CyFlow™ Counter System, a System to Test for CD4+ Lymphocytes, Receives WHO Prequalification
-Aiming to Help Improve the Quality of HIV Diagnosis and Treatment in Emerging Markets and Developing Countries-
more
2018/08/07
Sysmex and JVCKENWOOD Jointly Establish Company to Use Micro and Nano-Fabrication Technology to Develop and Manufacture IVD Biodevices
more
2018/07/10
Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services
more
2018/06/27
Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases
more
2018/05/14
Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19
-Contributing to Standardization in the Testing of Cancer Lymph Node Metastasis by Shortening Testing Times and Augmenting Processing Capacity-
more
2018/05/09
Sysmex Group Formulates New Long-Term Management Goals
Celebrating Our 50th Anniversary by Taking on New Challenges to Move to the Next Stage
more
2018/05/09
Sysmex Announces “Sysmex Eco-Vision 2025”
—To contribute to a sustainable society—
more
2018/05/08
Sysmex to Establish Bio-Diagnostic Reagent Center
Reinforcing Our Diagnostic Reagent Development and Production Function by Establishing a Location to Handle Integrated Development through Production and Distribution of Bio-Diagnostic Reagents
more
2018/05/02
Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor
more
2018/04/26
Sysmex to Launch JICA Project in the Republic of Ghana: "Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology”
more
2018/04/09
Sysmex Europe GmbH to Transfer Management of All European Installations of The DigniCap Scalp Cooling System Back to Dignitana AB
more
2018/04/06
Sysmex Launches Caresphere™, a New Network Solution
Supporting the Intelligent Use of Information for the Healthcare of the Future, Where the Use of Information is Accelerating
more
2018/04/03
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advancing Personalized Medicine
more
2018/04/03
Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics”
more
2018/03/21
Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan
Implementation of a one-stop bioresource project in Kyoto University, and the establishment of KBBM Co., Ltd. as a model of “industry-in-the-academia” industry-academia partnership
more
2018/03/18
OncoBEAM™ RAS CRC liquid biopsy test now reimbursed in Germany by BARMER
Effective immediately, cancer patients insured by BARMER now have access to Sysmex’s OncoBEAM™ RAS CRC IVD test.
more
2018/03/09
Sysmex to Be Special Sponsor of the Kobe Marathon 2018
-We are pleased to have sponsored this exciting event since its inception in 2011-
more
2018/02/20
Sysmex Celebrates Its 50th Anniversary of Establishment
Gratitude for All the Support over the Past 50 Years and a Commitment to Continue Taking on Challenges toward the Advancement of Healthcare.
more
2018/01/22
In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018
more
2018/01/22
In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018
more
2018/01/17
Liquid Biopsy performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS testing presented at ASCO GI 2018 meeting
more
2018/01/17
Liquid Biopsy performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS testing presented at ASCO GI 2018 meeting
more
